貝達藥業(300558.SZ)及子公司擬申請不超20億元融資額度
格隆匯 3 月 25日丨貝達藥業(300558.SZ)公佈,為滿足公司業務發展需要,公司及下屬子公司卡南吉、貝達診斷、夢工場控股、夢工場科技、貝夢醫藥、貝藥嵊州、Xcovery、醫科諾、貝達投資、Xcovery Betta擬申請融資總額不超過20億元人民幣,融資起始期限自此次股東大會審議通過本議案後至2021年度股東大會召開前。具體融資金額將視公司運營資金的實際需求確定,融資金額不超過前述融資額度。針對上述融資,公司與各子公司之間可互相提供擔保,擔保額度不超過20億元人民幣。為便於公司和子公司向銀行申請融資和擔保工作順利進行,提請公司股東大會及董事會授權公司董事長全權代表公司與銀行機構簽署融資項下的有關法律文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.